• This record comes from PubMed

Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey

. 2021 Jul 09 ; 11 (7) : e047245. [epub] 20210709

Language English Country England, Great Britain Media electronic

Document type Journal Article

Links

PubMed 34244267
PubMed Central PMC8273453
DOI 10.1136/bmjopen-2020-047245
PII: bmjopen-2020-047245
Knihovny.cz E-resources

OBJECTIVES: The Global Kidney Health Atlas (GKHA) is a multinational, cross-sectional survey designed to assess the current capacity for kidney care across all world regions. The 2017 GKHA involved 125 countries and identified significant gaps in oversight, funding and infrastructure to support care for patients with kidney disease, especially in lower-middle-income countries. Here, we report results from the survey for the second iteration of the GKHA conducted in 2018, which included specific questions about health financing and oversight of end-stage kidney disease (ESKD) care worldwide. SETTING: A cross-sectional global survey. PARTICIPANTS: Key stakeholders from 182 countries were invited to participate. Of those, stakeholders from 160 countries participated and were included. PRIMARY OUTCOMES: Primary outcomes included cost of kidney replacement therapy (KRT), funding for dialysis and transplantation, funding for conservative kidney management, extent of universal health coverage, out-of-pocket costs for KRT, within-country variability in ESKD care delivery and oversight systems for ESKD care. Outcomes were determined from a combination of desk research and input from key stakeholders in participating countries. RESULTS: 160 countries (covering 98% of the world's population) responded to the survey. Economic factors were identified as the top barrier to optimal ESKD care in 99 countries (64%). Full public funding for KRT was more common than for conservative kidney management (43% vs 28%). Among countries that provided at least some public coverage for KRT, 75% covered all citizens. Within-country variation in ESKD care delivery was reported in 40% of countries. Oversight of ESKD care was present in all high-income countries but was absent in 13% of low-income, 3% of lower-middle-income, and 10% of upper-middle-income countries. CONCLUSION: Significant gaps and variability exist in the public funding and oversight of ESKD care in many countries, particularly for those in low-income and lower-middle-income countries.

Bhumirajanagarindra Kidney Institute Bangkok Thailand

Centre for Kidney Disease Research The University of Queensland Saint Lucia Queensland Australia

Centre for Transplantation and Renal Research Westmead Institute for Medical Research Westmead New South Wales Australia

Department of Community Health Sciences University of Calgary Calgary Alberta Canada

Department of Infection Inflammation and Immunity University of Leicester Leicester UK

Department of Intensive Care Austin Health Heidelberg Victoria Australia

Department of Internal Disease and Nephrology North Western State Medical University named after 1 I Mechnikov Sankt Peterburg Russia

Department of Internal Medicine Saint Louis University Saint Louis Missouri USA

Department of Internal Medicine The Specialty Hospital Amman Jordan

Department of Medical Informatics Academic Medical Center University of Amsterdam Amsterdam Netherlands

Department of Medicine Cumming School of Medicine University of Calgary Calgary Alberta Canada

Department of Medicine King Chulalong Memorial Hospital Bangkok Thailand

Department of Medicine Monash University Clayton Victoria Australia

Department of Medicine University of Alberta Faculty of Medicine and Dentistry Edmonton Alberta Canada

Department of Medicine University of Hong Kong Hong Kong Hong Kong

Department of Nephrology Charles University Praha Czech Republic

Department of Nephrology Kidney Foundation Hospital and Research Institute Dhaka Bangladesh

Department of Nephrology Monash Medical Centre Clayton Clayton Victoria Australia

Department of Nephrology St Michael's Hospital Toronto Ontario Canada

Dialysis Unit CASMU IAMPP Montevideo Uruguay

Division of Nephrology and Hypertension University of California Irvine Medical Center Orange California USA

Division of Nephrology and Immunology University of Alberta Edmonton Alberta Canada

Division of Nephrology and Immunology University of Alberta Faculty of Medicine and Dentistry Edmonton Alberta Canada

Division of Nephrology Bezmialem Vakif Universitesi Istanbul Turkey

Division of Nephrology University of British Columbia Vancouver British Columbia Canada

Division of Nephrology University of Toronto Faculty of Medicine Toronto Ontario Canada

Faculty of Biology Medicine and Health The University of Manchester Manchester UK

Faculty of Medicine and Biomedical Sciences University of Yaounde 1 Faculty of Medicine and Biomedical Sciences Yaounde Cameroon

George Institute for Global Health New Dehli India

Hasheminejad Kidney Center Iran University of Medical Sciences Tehran Iran

Institute of Biomedical Ethics and the History of Medicine University of Zurich Institute of Biomedical Ethics History of Medicine Zurich Switzerland

Intensive Care Nephrology and Transplantation Department Assistance Publique Hopitaux de Paris Paris France

Kidney Research Center Chang Gung University College of Medicine Taoyuan Taiwan

Medicine University of Alberta Edmonton Alberta Canada

Medicine University of Cape Town Cape Town South Africa

Metro South Integrated Nephrology and Transplant Services Princess Alexandra Hospital Woolloongabba Queensland Australia

Monash Health Clayton Victoria Australia

Nephrology Development Clinical Center Tbilisi State Medical University Tbilisi Georgia

Nephrology Memphis VA Medical Center Memphis Tennessee USA

Oxford Kidney Unit Oxford University Hospitals NHS Trust Oxford UK

Population Health Sciences University of Bristol Bristol UK

Renal Division Peking University 1st Hospital Peking University Institute of Nephrology Beijing China

Salford Royal Hospitals NHS Trust Salford UK

The George Institute for Global Health Newtown New South Wales Australia

Urinary Tract Diseases Department University of Hassan 2 Casablanca Faculty of Science Ain Chock Casablanca Morocco

See more in PubMed

Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 2018;96:414–22. 10.2471/BLT.17.206441 PubMed DOI PMC

Bello AK, Alrukhaimi M, Ashuntantang GE, et al. . Global overview of health systems oversight and financing for kidney care. Kidney Int Suppl 2018;8:41–51. 10.1016/j.kisu.2017.10.008 PubMed DOI PMC

Jager KJ, Kovesdy C, Langham R, et al. . A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 2019;96:1048–50. 10.1016/j.kint.2019.07.012 PubMed DOI

Jager KJ, Fraser SDS. The ascending rank of chronic kidney disease in the global burden of disease study. Nephrol Dial Transplant 2017;32:ii121–8. 10.1093/ndt/gfw330 PubMed DOI

Liyanage T, Ninomiya T, Jha V, et al. . Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 2015;385:1975–82. 10.1016/S0140-6736(14)61601-9 PubMed DOI

Reeves A, Gourtsoyannis Y, Basu S, et al. . Financing universal health coverage—effects of alternative Tax structures on public health systems: cross-national modelling in 89 low-income and middle-income countries. The Lancet 2015;386:274–80. 10.1016/S0140-6736(15)60574-8 PubMed DOI PMC

Sachs JD. Achieving universal health coverage in low-income settings. The Lancet 2012;380:944–7. 10.1016/S0140-6736(12)61149-0 PubMed DOI

Organization WH . Strengthening health systems to improve health outcomes - WHO’s framework for action. Geneva: World Health Organization, 2007.

Jha V, Arici M, Collins AJ, et al. . Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int 2016;90:1164–74. 10.1016/j.kint.2016.09.009 PubMed DOI

Bello AK, Johnson DW, Feehally J, et al. . Global kidney health atlas (GKHA): design and methods. Kidney Int Suppl 2017;7:145–53. 10.1016/j.kisu.2017.08.001 PubMed DOI PMC

Bello AK, Levin A, Tonelli M, et al. . Assessment of global kidney health care status. JAMA 2017;317:1864. 10.1001/jama.2017.4046 PubMed DOI PMC

Stevens GA, Alkema L, Black RE, et al. . Guidelines for accurate and transparent health estimates reporting: the gather statement. The Lancet 2016;388:e19–23. 10.1016/S0140-6736(16)30388-9 PubMed DOI

Eysenbach G. Improving the quality of web surveys: the checklist for reporting results of Internet E-Surveys (cherries). J Med Internet Res 2004;6:1. 10.2196/jmir.6.3.e34 PubMed DOI PMC

Organization WH . Primary health care on the road to universal health coverage: 2019 global monitoring report. Geneva: World Health Organization, 2019.

Dodd R, Palagyi A, Guild L, et al. . The impact of out-of-pocket costs on treatment commencement and adherence in chronic kidney disease: a systematic review. Health Policy Plan 2018;33:1047–54. 10.1093/heapol/czy081 PubMed DOI

Ashuntantang G, Osafo C, Olowu WA, et al. . Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Glob Health 2017;5:e408–17. 10.1016/S2214-109X(17)30057-8 PubMed DOI

Harris DCH, Davies SJ, Finkelstein FO, et al. . Increasing access to integrated ESKD care as part of universal health coverage. Kidney Int 2019;95:33 10.1016/j.kint.2018.12.005 PubMed DOI

Organzation WH. Health systems financing: the path to universal coverage. Geneva, Switzerland: World Health Organization, 2010. PubMed PMC

Anand S, Bitton A, Gaziano T. The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS One 2013;8:e72860. 10.1371/journal.pone.0072860 PubMed DOI PMC

Tonelli M, Nkunu V, Varghese C, et al. . Framework for establishing integrated kidney care programs in low- and middle-income countries. Kidney Int Suppl 2020;10:e19–23. 10.1016/j.kisu.2019.11.002 PubMed DOI PMC

Tangcharoensathien V, Witthayapipopsakul W, Panichkriangkrai W, et al. . Health systems development in Thailand: a solid platform for successful implementation of universal health coverage. Lancet 2018;391:1205–23. 10.1016/S0140-6736(18)30198-3 PubMed DOI

van der Deen FS, Wilson N, Blakely T. A continuation of 10% annual tobacco tax increases until 2020: Modelling results for smoking prevalence by sex and ethnicity. N Z Med J 2016;129:4. PubMed

KDIGO . KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements 2013;3:150. PubMed

Liu FX, Gao X, Inglese G, et al. . A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Perit Dial Int 2015;35:406–20. 10.3747/pdi.2013.00204 PubMed DOI PMC

Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA 2018;319:1024. 10.1001/jama.2018.1150 PubMed DOI

Bradley EH, Sipsma H, Taylor LA. American health care paradox—high spending on health care and poor health. QJM 2016;110:61–5. PubMed

Obasola OI, Mabawonku I, Lagunju I. A review of e-health interventions for maternal and child health in Sub-Sahara Africa. Matern Child Health J 2015;19:1813–24. 10.1007/s10995-015-1695-0 PubMed DOI

Knight J, Perkovic V. The Affordable dialysis prize steams ahead. The Lancet 2016;387:1040. 10.1016/S0140-6736(16)00657-7 PubMed DOI

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...